Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
SENORES
₹1,418.10
₹1405.50
₹1487.90
₹570.10
₹1441.80
Markets Today
Historical Performance
As of 09-07-2026 17:16, Senores Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-1409.80 (-100.00%) from the previous close of ₹1409.8. The stock opened at ₹1425 and traded between ₹1405.5 and ₹1487.9, with a total traded volume of 498724 shares. The company has a market capitalization of ₹6257.8 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1441.8 and ₹570.1, respectively.
Senores Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 54.2, EPS of ₹26.39, and book value of ₹6.70. Profitability indicators show ROE of 12.35%. Senores Pharmaceuticals Ltd. has reported revenue of ₹649.5 Cr and net profit of ₹115.38 Cr.
Senores Pharmaceuticals Ltd. technical indicators include Day RSI at 68.24, Day MFI at 64.06, Day ADX at 44.67. Additional indicators include Commodity Channel Index (CCI) at 105.1 and Williams %R at -31.89. Momentum indicators show Day MACD at 72.27, Day MACD Signal Line at 72.78, DayATR at 57.95. Rate of Change indicators for Senores Pharmaceuticals Ltd. include ROC125 at 65.26 and ROC21 at 31.32.
Exponential moving averages include EMA5 at ₹1351.2, EMA10 at ₹1327.6, EMA12 at ₹1317.4, EMA20 at ₹1275.4, EMA26 at ₹1245.1, EMA50 at ₹1145.6, EMA100 at ₹1023.2, EMA200 at ₹896.2. Simple moving averages include SMA5 at ₹1351, SMA10 at ₹1323.6, SMA20 at ₹1281.4, SMA30 at ₹1213.4, SMA50 at ₹1118, SMA100 at ₹955.2, SMA150 at ₹905.4, SMA200 at ₹865.2.
Support levels for Senores Pharmaceuticals are placed at First Support ₹1334.70, Second Support ₹1310.60, Third Support ₹1280.20. Resistance levels are seen at First Resistance ₹1389.20, Second Resistance ₹1419.60, Third Resistance ₹1443.70. Senores Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 45.82%, FII holding at 3.64%, DII holding at 0%, public holding at 40.92%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 36.81 | 28.76 | 35.33 | 19.82 | 11.86 |
| Operating Expense | 40.29 | 29.69 | 33.81 | 20.97 | 14.60 |
| Operating Profit | -3.48 | -0.93 | 1.52 | -1.15 | -2.74 |
| Depreciation | 4.13 | 3.58 | 3.65 | 1.88 | 1.27 |
| Interest | 1.89 | 1.75 | 1.58 | 1.76 | 2.35 |
| Tax | 4.21 | 0.87 | 1.22 | 0.90 | 0.88 |
| Net Profit | 8.48 | 2.65 | 6.43 | 2.70 | 2.01 |
₹1418.10
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 45.8 | 45.8 | 45.8 | 45.8 | 45.8 | 45.8 |
| FII | 4.2 | 4.2 | 3.7 | 4.3 | 3.4 | 3.6 |
| DII | 11.8 | 9.6 | 9.5 | 8.6 | 9.3 | 9.7 |
| Public | 38.2 | 40.4 | 41 | 41.3 | 41.5 | 40.9 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 62.39 K | 1.71 L | 36.57% |
| Week | 1.19 L | 3.25 L | 36.45% |
| 1 Month | 1.76 L | 4.32 L | 40.68% |
| 6 Month | 1.45 L | 3.51 L | 41.31% |
High DVM Mid and Small Caps (subscription)
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Near 52 Week High
Stock gained more than 20% in one month
Highest Recovery from 52 Week Low
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹2,027.20 | ₹807 | ₹1,625 | ₹4,508 | ₹660 |
| % Change | 2.41% | 0.84% | 0.81% | -0.69% | 1.95% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | ₹642.26 | ₹1,421.59 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | ₹172.89 | ₹-73.80 | ₹257.90 | ₹255.19 |
| PE TTM | 65.70 | 53.00 | -252.70 | 41.10 | 40.10 |
| 1 Year Return | 87.27 | 36.75 | -18.59 | -14.34 | 14.03 |
| ROCE | 31.54 | 24.22 | 0.59 | - | 11.40 |
Innova Captab Ltd.
₹ 992.00
+0.93%
Blue Jet Healthcare Ltd
₹ 575.75
+2.32%
Concord Biotech Ltd.
₹ 1311.20
+4.08%
Aarti Pharmalabs Ltd.
₹ 704.00
+2.59%
Supriya Lifescience Ltd.
₹ 876.50
+1.72%
Alivus Life Sciences Ltd.
₹ 1145.90
+1.40%
Cohance Lifesciences Ltd.
₹ 441.00
+2.37%
Eris Lifesciences Ltd.
₹ 1430.00
+0.99%
Syngene International Ltd.
₹ 415.85
+1.03%
Alembic Pharmaceuticals Ltd.
₹ 816.00
+0.58%
Sun Pharma Advanced Research Company Ltd.
₹ 278.05
+2.99%
Strides Pharma Science Ltd.
₹ 1072.00
-0.81%
FDC Ltd.
₹ 431.70
+1.96%
Shilpa Medicare Ltd.
₹ 624.80
+4.95%
Jubilant Pharmova Ltd.
₹ 972.00
+0.13%
Natco Pharma Ltd.
₹ 961.55
-0.49%
Caplin Point Laboratories Ltd.
₹ 2626.00
+3.86%
Marksans Pharma Ltd.
₹ 278.80
+5.83%
Orchid Pharma Ltd.
₹ 1050.00
+4.76%
Bliss GVS Pharma Ltd.
₹ 526.90
+2.72%
Sanofi India Ltd.
₹ 3349.00
-0.96%
Procter & Gamble Health Ltd.
₹ 6600.00
+5.39%
Jeena Sikho Lifecare Ltd.
₹ 590.00
+4.71%
By signing up I certify terms, conditions & privacy policy